1. Home
  2. UBX vs GIFT Comparison

UBX vs GIFT Comparison

Compare UBX & GIFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UBX
  • GIFT
  • Stock Information
  • Founded
  • UBX 2009
  • GIFT 1999
  • Country
  • UBX United States
  • GIFT United States
  • Employees
  • UBX N/A
  • GIFT N/A
  • Industry
  • UBX Biotechnology: Pharmaceutical Preparations
  • GIFT Catalog/Specialty Distribution
  • Sector
  • UBX Health Care
  • GIFT Consumer Discretionary
  • Exchange
  • UBX Nasdaq
  • GIFT Nasdaq
  • Market Cap
  • UBX 36.9M
  • GIFT 38.5M
  • IPO Year
  • UBX 2018
  • GIFT N/A
  • Fundamental
  • Price
  • UBX $1.94
  • GIFT $1.38
  • Analyst Decision
  • UBX Strong Buy
  • GIFT Strong Buy
  • Analyst Count
  • UBX 2
  • GIFT 1
  • Target Price
  • UBX $7.00
  • GIFT $4.00
  • AVG Volume (30 Days)
  • UBX 203.3K
  • GIFT 111.9K
  • Earning Date
  • UBX 04-14-2025
  • GIFT 03-04-2025
  • Dividend Yield
  • UBX N/A
  • GIFT N/A
  • EPS Growth
  • UBX N/A
  • GIFT N/A
  • EPS
  • UBX N/A
  • GIFT N/A
  • Revenue
  • UBX N/A
  • GIFT $86,439,146.00
  • Revenue This Year
  • UBX N/A
  • GIFT $3.23
  • Revenue Next Year
  • UBX $33.62
  • GIFT $25.39
  • P/E Ratio
  • UBX N/A
  • GIFT N/A
  • Revenue Growth
  • UBX N/A
  • GIFT N/A
  • 52 Week Low
  • UBX $0.94
  • GIFT $0.50
  • 52 Week High
  • UBX $3.10
  • GIFT $4.50
  • Technical
  • Relative Strength Index (RSI)
  • UBX 48.69
  • GIFT N/A
  • Support Level
  • UBX $1.99
  • GIFT N/A
  • Resistance Level
  • UBX $2.17
  • GIFT N/A
  • Average True Range (ATR)
  • UBX 0.22
  • GIFT 0.00
  • MACD
  • UBX -0.05
  • GIFT 0.00
  • Stochastic Oscillator
  • UBX 22.41
  • GIFT 0.00

About UBX Unity Biotechnology Inc.

Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone primarily produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.

About GIFT RDE Inc. Common Stock

Giftify Inc through its wholly-owned subsidiary, has been in the business of connecting digital consumers, businesses and communities with dining and merchant deal options throughout the United States. The company connects digital consumers, businesses, and communities offering dining and merchant deal options nationwide restaurants, and retailers to customers. The Company buys merchant gift cards from the general public and distributors at a discount and then resells them at a markup.

Share on Social Networks: